Unpacking Trump’s healthcare regulatory agenda: Our predictions for rulemaking in the new administration
Explore Trump’s healthcare regulatory agenda, focusing on four key rule-making periods: finalized rules subject to reversal, proposed rules, ongoing models, and future rulemaking.
At a glance
Read on to get our full commentary, or use the links below to jump to a specific area of interest:
Yesterday, Donald Trump was sworn in as President, marking only the second time in U.S. history that a president will serve two non-consecutive terms (the first was Grover Cleveland in the late 19th century, in case you haven’t read that about a dozen times since the election). This puts Trump in the unusual position of having both a past presidential record to be analyzed and an interest in reshaping the later-term decisions of his predecessor/successor. In today’s blog post, we are going to take advantage of this chronological quirk to explore Trump’s healthcare regulatory agenda, focusing on four key rule-making periods:
- Recently finalized rules subject to reversal;
- Proposed rules now inherited by the new administration;
- Ongoing healthcare models;
- What new rules to expect in the next four years.
In the first three sections, we’ll take a look at the rules that are most likely to stay, most likely to go, and where there is still quite a bit of uncertainty.
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
This week in healthcare: What happened and what it means
What the 2026 midterm election results mean for healthcare policy
Healthcare policy and payment: What leaders need to know now